ZA837789B - Cysteine-depleted muteins of biologically active proteins - Google Patents

Cysteine-depleted muteins of biologically active proteins

Info

Publication number
ZA837789B
ZA837789B ZA837789A ZA837789A ZA837789B ZA 837789 B ZA837789 B ZA 837789B ZA 837789 A ZA837789 A ZA 837789A ZA 837789 A ZA837789 A ZA 837789A ZA 837789 B ZA837789 B ZA 837789B
Authority
ZA
South Africa
Prior art keywords
cysteine
biologically active
active proteins
depleted muteins
muteins
Prior art date
Application number
ZA837789A
Other languages
English (en)
Inventor
F Mark David
Leo S Lin
Shi-Da Yu Lu
Original Assignee
Cetus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Corp filed Critical Cetus Corp
Publication of ZA837789B publication Critical patent/ZA837789B/xx

Links

ZA837789A 1982-10-19 1983-10-19 Cysteine-depleted muteins of biologically active proteins ZA837789B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43515482A 1982-10-19 1982-10-19

Publications (1)

Publication Number Publication Date
ZA837789B true ZA837789B (en) 1984-11-28

Family

ID=23727220

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA837789A ZA837789B (en) 1982-10-19 1983-10-19 Cysteine-depleted muteins of biologically active proteins

Country Status (4)

Country Link
JP (4) JPS5993093A (enrdf_load_stackoverflow)
IL (1) IL90047A (enrdf_load_stackoverflow)
IN (1) IN161992B (enrdf_load_stackoverflow)
ZA (1) ZA837789B (enrdf_load_stackoverflow)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL76360A0 (en) 1984-09-26 1986-01-31 Takeda Chemical Industries Ltd Mutual separation of proteins
FI862531A0 (fi) * 1984-10-15 1986-06-13 Cetus Corp Tumoernekrosisfaktor.
JP2675294B2 (ja) * 1984-10-15 1997-11-12 カイロン コーポレイション ヒト腫瘍壊死因子
US4572798A (en) * 1984-12-06 1986-02-25 Cetus Corporation Method for promoting disulfide bond formation in recombinant proteins
JP2721854B2 (ja) * 1984-12-21 1998-03-04 大塚製薬株式会社 抗腫瘍活性物質
JP2583753B2 (ja) * 1984-12-21 1997-02-19 大塚製薬株式会社 抗腫瘍活性物質およびその製造法
IE58574B1 (en) * 1985-04-22 1993-10-06 Genentech Inc Human tissue plasminogen activator mutants, methods and intermediates therefor, and compositions using such mutants
US4818698A (en) * 1985-08-23 1989-04-04 Toyo Jozo Co., Ltd. Polypeptides and preparation process thereof
NZ226543A (en) * 1987-10-22 1992-02-25 Merck & Co Inc Recombinant mutant acidic fibroblast growth factor
EP0383599B1 (en) * 1989-02-17 1996-02-07 Merck & Co. Inc. Protein anti-cancer agent
NZ232900A (en) * 1989-03-22 1993-08-26 Merck & Co Inc Pseudomonas exotoxin a, pe 40 domain derivatives
US6207798B1 (en) 1989-08-03 2001-03-27 Merck & Co., Inc. Modified PE40 toxin fusion proteins
JPH0751621A (ja) * 1993-08-12 1995-02-28 Kansei Kogyo Kk 静電吸着による管内面更生工法
AR034749A1 (es) * 2001-07-09 2004-03-17 Schering Ag Formulaciones de interferon beta humano
US20050008616A1 (en) * 2003-07-11 2005-01-13 Schering Aktiengesellschaft Recombinant human interferon-beta-1b polypeptides
US20240270807A1 (en) * 2020-04-29 2024-08-15 Genopharm Inc. Recombinant protein having fused interferon-beta mutein and antibody, and pharmaceutical composition comprising same

Also Published As

Publication number Publication date
JPS6128393A (ja) 1986-02-08
JPS6128384A (ja) 1986-02-08
JPH057996B2 (enrdf_load_stackoverflow) 1993-01-29
JPH0380475B2 (enrdf_load_stackoverflow) 1991-12-25
IL90047A (en) 1992-12-01
JPS5993093A (ja) 1984-05-29
IN161992B (enrdf_load_stackoverflow) 1988-03-12
JPS6128394A (ja) 1986-02-08
JPS6357440B2 (enrdf_load_stackoverflow) 1988-11-11

Similar Documents

Publication Publication Date Title
EP0210461A3 (en) Physiologically active polypeptide buf-3
AU5518086A (en) Cysteine-depleted muteins of biologically active human tumor necrosis factor proteins
DE3370378D1 (en) Biologically active composition and immunoassay using the same
ZA837789B (en) Cysteine-depleted muteins of biologically active proteins
HUT46539A (en) Biologically active copolimers
IT1167607B (it) Polipeptide avente attivita' di interferon, composizione che lo contiene e procedimento di preparazione
DE3377654D1 (en) Hypocholesterolemically active protein
EP0129582A4 (en) BIOLOGICALLY ACTIVE PEPTIDES AND PROTEINS FOR ORAL ADMINISTRATION.
IL75828A (en) Immobilization by biologically active proteins
IT1170302B (it) Polipeptide avente attivita' di interferon, composizione che lo contiene e procedimento di preparazione
IT1164861B (it) Polipeptide avente attivita' di interferon, composizione che lo contiene e procedimento di preparazione
NO841827L (no) Biologisk aktive polypeptider
AU557783B2 (en) Biologically active peptides
GB8616700D0 (en) Biologically active substances
GB8300998D0 (en) Derivatives of biologically active substituted tin compounds
IE830105L (en) Preparation of optically active mercaptoalkanoylaminoacids
DE3264659D1 (en) Biologically active peptides
GB2086396B (en) Biologically active peptides
IL90047A0 (en) Cysteine-depleted muteins of biologically active proteins
GB8309547D0 (en) Biologically active peptides
DE3361316D1 (en) Preparation of optically active 4-demethoxydaunomycinone
GB8332164D0 (en) Of 4949 physiologically active substance
IE832922L (en) Obtaining biologically active protein¹¹heterologous proteins
JPS5668651A (en) Novel biologically active peptide
EP0253245A3 (en) Biologically active peptides tan-866